---
figid: PMC10855537__ijms-25-01557-g003
pmcid: PMC10855537
image_filename: PMC10855537__ijms-25-01557-g003.jpg
figure_link: /pmc/articles/PMC10855537/figure/F3/
number: Figure 3
figure_title: (A) The downstream effects of FGFR receptors when activated by a ligand.
caption: (A) The downstream effects of FGFR receptors when activated by a ligand.
  (B) How this signalling pathway is disrupted by Erdafitinib, inhibiting the progression
  of tumour cells through blocking the activation of the PI3K/AkT/mTOR signalling
  cascade. Created using BioRender.com (accessed on 30 November 2023)
article_title: 'Mini-Review: Current Bladder Cancer Treatmentâ€”The Need for Improvement'
citation: Emily Gill, et al. Int J Mol Sci. 2024 Feb;25(3).
year: '2024'
pub_date: 2024-2-
epub_date: 2024-1-26
doi: 10.3390/ijms25031557
journal_title: International Journal of Molecular Sciences
journa_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords:
- bladder cancer treatment
- non-muscle-invasive bladder cancer
- muscle-invasive bladder cancer
- radial cystectomy
- transurethral resection of the bladder tumour
- biomarkers
---
